2026 Marketing Predictions from Healthtech Leaders

Bypaulgruensfelder
Healthtech Marketing Show
December 2025

Read Full Article →

AI-Generated Summary

Marketing and PR leaders from across the healthtech sector share predictions for 2026. They identify hyper-personalised messaging—driven by AI co-pilots that assist both marketers and buyers—as the dominant trend, alongside rising buyer scepticism that demands higher content quality and more authentic brand voices. The panel recommends investing in storytelling and content differentiation to cut through increasing market noise.

Why It Matters

For growth-stage healthtech companies and health system marketing teams, understanding how the buyer environment is shifting in 2026 informs both channel strategy and message design. The AI co-pilot dynamic, in particular, is changing how buyers evaluate vendors.

digital marketing
growth strategy
brand
AI co-pilots
hyper-personalisation
2026 trends

While we aim to share useful and relevant resources, we can’t guarantee the accuracy of all third-party content. Always apply professional judgment when acting on information from external sources.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Health System Leaders on Costs, Innovation, and the Affordability Challenge

    Bypaulgruensfelder

    Top U.S. health system executives say affordability and cost pressure now sit at the center of nearly every strategic decision. In a Chief Healthcare Executive roundtable, leaders including Hackensack Meridian Health CEO Robert Garrett argued that systems must shift from treating illness toward preventing chronic disease and keeping communities healthy. Panelists framed innovation, particularly AI, as a double-edged force: either an ingredient in solving the affordability challenge or a threat to traditional business models. The group sees significant potential for new technology to transform operations and care delivery, while cautioning that disruption is inevitable and that executives must actively manage change rather than react to it.

  • Local Search in the Age of AI: 6 Moves for Healthcare Marketers

    Bypaulgruensfelder

    Winning healthcare local search now means appearing as the trusted answer across search engines, maps, and AI tools—not simply ranking on Google. Press Ganey outlines six priorities: maintain complete, accurate location and provider listings; build robust provider profiles that serve as both content and conversion assets; manage reputation across every directory and review platform rather than Google alone; actively generate patient reviews; use structured data and authoritative content so AI engines can understand and cite you; and measure outcomes like appointments instead of rankings or traffic. With 89% of consumers calling accurate online information essential to choosing a provider, inconsistent data now costs patients before they ever book.